Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Merck Announces Major FOB Initiative With Its New Business Unit

09 Dec 2008

Merck BioVentures plans to launch follow-on version of Amgen’s Aranesp by 2012.

Related Content

Senate Biosimilars Bill Readied For Take-Off In Next Congress

25 Nov 2008

FDA Cannot Escape Congressional Crosshairs

08 Dec 2008

Follow-On Biologics Market Unfolding: Big Pharma Signals An Interest

06 Oct 2008

Big Pharma May Be Big Player in Follow-On Biologics Market

01 Apr 2008

Pharma's New Follow-On Strategy

01 Feb 2008

Big Pharma's Leap into Biologics: Bridging both Scientific and Cultural Gaps

01 Oct 2007

GlaxoSmithKline Breaks Out of Its Small-Molecule Mind-Set

01 Jan 2007

The Next-Generation Antibody Players

01 Feb 2006

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.